Tonix Pharmaceuticals Holding Corp.
TNXP
$38.00
$2.156.00%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 9.83M | 10.04M | 10.09M | 11.29M | 12.46M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 9.83M | 10.04M | 10.09M | 11.29M | 12.46M |
Cost of Revenue | 6.95M | 7.05M | 7.77M | 8.95M | 9.77M |
Gross Profit | 2.88M | 2.99M | 2.33M | 2.34M | 2.69M |
SG&A Expenses | 49.60M | 40.90M | 40.10M | 36.14M | 37.15M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 92.22M | 82.49M | 87.84M | 93.88M | 107.64M |
Operating Income | -82.38M | -72.45M | -77.74M | -82.59M | -95.19M |
Income Before Tax | -81.42M | -131.93M | -130.04M | -135.25M | -149.01M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -81.42 | -131.93 | -130.04 | -135.25 | -149.01 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -81.42M | -131.93M | -130.04M | -135.25M | -149.01M |
EBIT | -82.38M | -72.45M | -77.74M | -82.59M | -95.19M |
EBITDA | -80.17M | -69.07M | -73.85M | -78.17M | -90.29M |
EPS Basic | -39.34 | -1.96K | -2.49K | -4.66K | -4.64K |
Normalized Basic EPS | -24.37 | -324.00 | -657.26 | -651.16 | -636.86 |
EPS Diluted | -39.34 | -1.96K | -2.49K | -4.66K | -4.64K |
Normalized Diluted EPS | -24.37 | -324.00 | -657.26 | -651.16 | -636.86 |
Average Basic Shares Outstanding | 16.14M | 8.85M | 2.95M | 690.10K | 68.90K |
Average Diluted Shares Outstanding | 16.14M | 8.85M | 2.95M | 702.60K | 81.40K |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |